Literature DB >> 19799360

[239Pu and chromosomal aberrations in human peripheral blood lymphocytes].

N D Okladnikova, S V Osovets, T I Kudriavtseva.   

Abstract

The genome status in somatic cells was assessed using the chromosomal aberration (CA) test in peripheral blood lymphocytes from 194 plutonium workers exposed to occupational radiation mainly from low-transportable compounds of airborne 230Pu. Pu body burden at the time of cytogenetic study varied from values close to the method sensitivity to values multiply exceeding the permissible level. Standard (routine) methods of peripheral blood lymphocytes cultivation were applied. Chromatid- and chromosomal-type structural changes were estimated. Aberrations were estimated per 100 examined metaphase cells. The quantitative relationship between the CA frequency and Pu body burden and the absorbed dose to the lung was found. Mathematical processing of results was carried out based on the phenomenological model. The results were shown as theoretical and experimental curves. The threshold of the CA yield was 0.43 +/- 0.03 kBq (Pu body burden) and 6.12 +/- 1.20 cGy (absorbed dose to the lung).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19799360

Source DB:  PubMed          Journal:  Radiats Biol Radioecol        ISSN: 0869-8031


  2 in total

1.  mFISH analysis of chromosome aberrations in workers occupationally exposed to mixed radiation.

Authors:  Natalia V Sotnik; Sergey V Osovets; Harry Scherthan; Tamara V Azizova
Journal:  Radiat Environ Biophys       Date:  2014-04-09       Impact factor: 1.925

Review 2.  Eurados review of retrospective dosimetry techniques for internal exposures to ionising radiation and their applications.

Authors:  A Giussani; M A Lopez; H Romm; A Testa; E A Ainsbury; M Degteva; S Della Monaca; G Etherington; P Fattibene; I Güclu; A Jaworska; D C Lloyd; I Malátová; S McComish; D Melo; J Osko; A Rojo; S Roch-Lefevre; L Roy; E Shishkina; N Sotnik; S Y Tolmachev; A Wieser; C Woda; M Youngman
Journal:  Radiat Environ Biophys       Date:  2020-05-05       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.